Genomma Lab Internacional, S.A.B. de C.V. (BMV:LAB.B)
14.04
-0.18 (-1.27%)
At close: Aug 11, 2026
Genomma Lab Internacional Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Genomma Lab Internacional stock has a consensus rating of "Buy" and an average price target of $22.67. The average 1-year stock price forecast is 61.47% higher than the current stock price, while the lowest is $16.00 (+13.96%) and the highest is $29.00 (+106.55%).
Price Target: $22.67 (+61.47%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Genomma Lab Internacional stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Financial Forecast
Revenue This Year
18.72B
from 17.54B
Increased by 6.74%
Revenue Next Year
19.19B
from 18.72B
Increased by 2.50%
EPS This Year
2.56
from 1.61
Increased by 59.01%
EPS Next Year
2.13
from 2.56
Decreased by -16.70%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MXN.